Showing results (11-20 of 41) with videos related to
Sort By:
Pageof 5
Medicina (Kaunas, Lithuania)|November 11, 2022
Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching AnalysisWei Zeng, Yi Liu, Chuandong Wang, et al.Disease Markers|March 28, 2015
Secernin-1 contributes to colon cancer progression through enhancing matrix metalloproteinase-2/9 exocytosisShengtao Lin, Tao Jiang, Yang Yu, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 29, 2023
Efficacy and long-term prognosis of gastrojejunostomy for malignant gastric outlet obstruction: A systematic review and Bayesian network meta-analysisChuandong Wang, Xiaojuan Zhang, Yi Liu, et al.Applied Optics|April 1, 2020
Integrated principal component analysis denoising technique for phase-sensitive optical time domain reflectometry vibration detectionAtubga David Atia Ibrahim, Shengtao Lin, Ji Xiong, et al.Ultrasound in Medicine & Biology|February 7, 2015
Quantifying activation of perfluorocarbon-based phase-change contrast agents using simultaneous acoustic and optical observationSinan Li, Shengtao Lin, Yi Cheng, et al.Gland Surgery|November 10, 2022
The analysis and validation of the prediction value of conventional and contrast-enhanced ultrasonography for <i>BRAF</i> mutant papillary thyroid microcarcinomaHuilin Li, Jiaojiao Ma, Xuehua Xi, et al.Current Medicinal Chemistry|June 24, 2026
Exploring the Lactylation Landscape: A Bibliometric Analysis of Metabolic-Epigenetic Interplay in Disease Mechanisms and Therapeutic PotentialYifan Chen, Shengbin Zheng, Yulong Mi, et al.Physics in Medicine and Biology|February 1, 2018
Imaging of vaporised sub-micron phase change contrast agents with high frame rate ultrasound and opticsShengtao Lin, Ge Zhang, Akaki Jamburidze, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 14, 2015
Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitorsXiaoqing Zhang, Junwei Fan, Yuping Li, et al.International Journal of Clinical and Experimental Pathology|November 18, 2014
Overexpression of eIF3e is correlated with colon tumor development and poor prognosisZhi Li, Shengtao Lin, Tao Jiang, et al.Pageof 5